India's pharmaceutical sector flaunts a complex landscape, where the presence of both large-scale global players and a multitude of domestic firms creates a dynamic yet often disparate market. While this diversity can foster advancement, concerns regarding monopoly power are increasingly coming to the forefront. A handful of multinationals have man